ShangPharma Corp. (SHP) Misses Q3 EPS by 5c; Lowers FY12 Revs Outlook
Tweet Send to a Friend
ShangPharma Corp. (NYSE: SHP) reported Q3 EPS of $0.15, $0.05 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $31.9 million versus the consensus estimate of $34.05 million.
ShangPharma Corp. sees FY2012 revenue of $125-128 million, versus prior guidance of $131.7-136.2 million and the consensus of $132.94 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
ShangPharma Corp. sees FY2012 revenue of $125-128 million, versus prior guidance of $131.7-136.2 million and the consensus of $132.94 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Autodesk, Inc. (ADSK) Misses Q1 EPS by 3c, Offers Guidance
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
